1)
Release of excitatory amino acids from cultured hippocampal astrocytes induced
by a hypoxic-hypoglycemic stimulation.
Ogata
T., Nakamura Y., Shibata T. and Kataoka K.
Journal
of Neurochemistry
1992,
vol. 58, No. 5, pp. 1957-1959
2)
Steroid hormones protect spinal cord neurons from glutamate toxicity.
Ogata
T., Nakamura Y., Tsuji K., Shibata T. and Kataoka K.
Neuroscience
1993,
vol. 55, No. 2, pp. 445-449
3)
Adenosine enhances intracellular Ca2+ mobilization in conjunction with
metabotropic glutamate receptor activation by t-ACPD in cultured hippocampal
satrocytes.
Ogata
T., Nakamura Y., Tsuji K., Shibata T., Kataoka K. and Schubert P.
Neuroscience
Letters
1994,
vol. 170, pp. 5-8
4)
A marked increase in intracellular Ca2+ concentration induced by acromelic acid
in cultured rat spinal neurons.
Ogata
T., Nakamura Y., Tsuji K., Shibata T., Kataoka K., Ishida M. and Shinozaki H.
Neuropharmacology
1994,
vol. 33, No. 9, pp. 1079-1085
5)
Rapid decrease in ATP content without recovery phase during glutamate-induced
cell death in cultured spinal neurons.
Tsuji
K., Nakamura Y., Ogata T., Shibata T.and Kataoka K.
Brain
Research
1994,
vol. 662, pp. 289-292
6)
Neurotoxicity of acromelic acid in cultured neurins from rat spinal cord.
Tsuji
K., Nakamura Y., Ogata T., Shibata T., Kataoka K, Ishida M. and Shinozaki H.
Neuroscience
1995,
vol. 68, No. 2, pp. 585-591
7)
A possible mechanism for the hypoxia-hypoglycemia-induced release of excitatory
amino acids from cultured hippocampal astrocytes.
Ogata
T., Nakamura Y., Tsuji K., Shibata T. and Kataoka K.
Neurochemical
Research
1995,
vol. 20, No.6, pp. 737-743
8)
Transient increase of cyclic AMP induced by glutamate in cultured neurons from
rat spinal cord.
Tsuji
K., Nakamura Y., Ogata T., Shibata T.and Kataoka K.
Journal
of Neurochemistry
1995,
vol. 65, No. 4, pp. 1816-1822
9)
Role of aspartate in ischemic spinal cord damage
Ogata
T., Nakamura Y., Tsuji K., Okumura H., Kataoka K. and Shibata T.
Journal
of Orthopaedic Research
1996,
vol. 14, No. 3, pp. 504-510
10)
Potentiated cAMP rise in metabotropically stimulated rat cultured astrocytes by
a Ca2+-related A1/A2 adenosine receptor cooperation.
Ogata
T., Nakamura Y.and Schubert P.
European
Journal of Neuroscience
1996,
vol. 8, pp. 1124-1131
11)
Modulation of glial cell signalling by adenosine and pharmacological
reinforcement: a neuroprotective strategy?
Schubert
P., Ogata T., Ferroni S., McRae A., Nakamura Y.and Rudolphi K.
Molecular
and Chemical Neuropharmacology
1996,
vol. 28, pp. 185-190
12)
Ischemic neuronal damage; How does mild hypothermia modulate it?
Kataoka
K., Mitani A., Yanase H., Zhang L., Higashihara M., Ogata T., Tsuji K.,
Nakamura Y., McRae A., Ogita K. and Yoneda Y.
Molecular
and Chemical Neuropharmacology
1996,
vol. 28, pp. 191-195
13)
Programmed cell death in rat microglia is controlled by extracellular
adenosine.
Ogata
T. and Schubert P.
Neuroscience
Letters
1996,
vol. 218, pp. 91-94
14)
Post-ischaemic glial responses and amyloid accumulation are modified by
propentofylline: a neuroprotective pharmacon for Alzheimer's disease?
McRae
A., Schubert P., Ogata T., Nakamura Y., Ling E.A., Kaur C. and Rudolphi K.
In:
"Biology, Diagnosis and Therapeutics" (K. Iqbal, B. Winblad, T.
Nishimura, M. Takeda and H.M. Wisniewski, Eds.) John Wiley and Sons Ltd.
1997,
pp. 759-767
15)
Protective mechanisms of adenosine in neurons and glial cells.
Schubert
P., Ogata T., Marchini C., Ferroni S. and Rudolphi K.
In:
"Neuroprotective Agents" (W. Slikker and B. Trembly, Eds.) Ann.
N.Y.Acad.Sci.
1997,
vol. 825, pp. 1-10
16)
Inhibitory effect of adenosine agonists and propentofylline on the
proliferation and transformation of cultured microglia.
Nakamura
Y., Si Q.S., Kataoka K., Ogata T. and Schubert P.
In:
"The Role of Adenosine in the Nervous System" (Y. Okada, Ed.),
pp.97-102, Elsevier,
17)
Support of homeostatic glial cell signaling: a novel therapeutic approach by
propentofylline.
Schubert
P., Ogata T., Rudolphi K., Marchini C., McRae A. and Ferroni S.
In:
"Cerebrovascular Pathology in Alzheimer's disease" (J.C.de la Torre
and V. Hachinski, Eds.)
1997,
vol. 826, pp. 337-347
18)
Homeostatic effects of adenosine on potentially neurotoxic glial cell
activation.
Schubert
P., Ogata T., Marchini C. and Kataoka K.
In
"Neurochemistry" (Teelken and Korf, Ed.), pp.83-90, Plenum Press,
19)
Pathological immuno-reactions of glial cells in Alzheimer's disease and
possible sites of interference.
Schubert
P., Ogata T.,
Journal
of Neurotransmission
1998,
vol.54, pp.167-174
20)
Differential regulation of microglial activation by propentofylline via cAMP
signaling.
Si
Q., Nakamura Y., Ogata T., Kataoka K. and Schubert P.
Brain
Research
1998,
vol. 812, pp. 97-104
21)
Substance P regulates the function of rabbit cultured osteoclast; increase of
intracellular free calcium concentration and enhancement of bone resorption.
Mori
T., Ogata T., Okumura H., Shibata T., Nakamura Y. and Kataoka K.
Biocheminal
and Biophysical Research Communications
1999,
vol. 262, pp.418-422
22) Mild hypothermia amelioration of
damage during rat spinal cord injury: inhibition of pathological microglial
proliferation and improvement of hind-limb motor function.
Ogata T., Morino T., Takeba J.,
Matsuda Y., Okumura H., Shibata T., Schubert P. and Kataoka K.
In "Brain Hypothermia" (N.
Hayashi, Ed.), pp.47-54, Springer-Verlag,
23) Cascading glia reactions: a
common pathomechanism and its differentiatedcontrol by cyclic nucleotide
signaling.
Schubert P., Morino T.,
Ann. N.Y.Acad.Sci.
2000, vol. 903, pp. 24-34
24) Glia-related pathomechanisms in
Alzheimer's disease: a therapeutic target?
Schubert P., Ogata T., Marchini C.
and Ferroni S.
Mechanisms of Ageing and Development
2001, vol. 123, pp. 47–57
25) Recovery of
deficient cholinergic calcium signaling by adenosine in cultured rat cortical
astrocytes.
Ferroni S., Marchini
C., Ogata T. and Schubert P.
J. Neurosci. Res.
2002, vol. 68, pp 615-621
26) Prostaglandin E1
analog inhibits the microglia function: suppression of
lipopolysaccharide-induced nitric oxide and TNF-a release
Chuai M., Ogata T.,
Morino T., Okumura H., Yamamoto H. and Schubert P.
J Orthopedic Res.
2002, vol. 20, pp
1246-1252
27) Serotonergic
signaling inhibits hyperalgesia induced by spinal cord damage
Horiuchi H., Ogata T.,
Morino T., Takeba, J., Yamamoto H.
Brain Res.
2003, vol 963, pp
312-320
28) Delayed neuronal damage related to microglia
proliferation after mild spinal cord compression injury
Morino, T., Ogata, T. Horiuchi,
H. Takeba, J., Okumura, H.,
Neuroscience Research
2003, vol. 46, pp 309-318
29) Adenosine triphosphate inhibits cytokine release from lipopolysaccharide-activated
microglia via P2y receptors
Ogata, T., Chuai, M., Morino, T., Yamamoto, H., Nakamura Y., Schubert,
P.
Brain
Research
2003,
vol. 981, pp 174-183
30) Continuous intrathecal infusion
of SB203580, a selective inhibitor of p38 mitogen-activated protein kinase,
reduces the damage of hind-limb function after thoracic spinal cord injury in
rat.
Horiuchi,
H., Ogata, T., Morino, T., Chuai, M., Yamamoto, H.
Neuroscience Research
2003, vol. 47, pp. 209-217
31)
A simple bone cyst located in the pedicle of the lumbar vertebra; A case
report.
Ogata,
T., Matsuda, Y., Hino, M., Kawatani, Y., Sogabe, H., Yamamoto, H.
J.
Spinal Disord. Tech.
2004,
vol. 17 (4), pp. 339-342
32)
Intraosseous gouty tophus of the talus, treated by total curettage and calcium
phosphate cement filling: a case report.
Morino,
T., Fujita, M., Kariyama, K., Yamakawa, H., Ogata, T., Yamamoto, H.
Foot
and Ankle International
2007,
vol. 28 (1), pp. 126-128
33)
Real-time direct measurement of spinal
cord blood flow at the site of compression: relationship between blood flow
recovery and motor deficiency in spinal cord injury.
Hamamoto Y, Ogata T, Morino T, Hino
M, and Yamamoto H
Spine 2007,
vol. 32 (18), pp. 1955-1962
34)
A periosteal chondroma located in lumbar spinal canal:
A case report
Ogata T,
Journal
of Neurosurgery: Spine 2007, vol. 7(4), pp. 454-458
35) Microglia inhibition
is a target of mild hypothermic treatment after the spinal cord injury.
Morino T, Ogata T, Takeba J, Yamamoto H.
Spinal Cord. 2008;46(6):425-31.
36) Resolution
of intraspinal retro-odontoid cyst associated with os odontoideum following
posterior fixation.
Ogata T, Kawatani Y, Morino T,
and Yamamoto H
J.
Spinal Disord. Tech. 2009; 22(1): 58-61
37) Intrathecal transplantation of autologous macrophages
genetically modified to secrete proenkephalin ameliorated hyperalgesia and
allodynia following peripheral nerve injury in rats.
Hino
M, Ogata T, Morino T, Horiuchi H, Yamamoto H.
Neuroscience Research 2009;
64:56-62
38) Prostaglandin
E1 analog increases spinal cord blood flow at the point of compression during
and after experimental spinal cord injury.
Hamamoto Y, Ogata T, Morino T, Hino
M, Yamamoto H
Spinal Cord. 2010; 48: 149-153
39) Adenosine A1 receptor agonists reduce
hyperalgesia after spinal cord injury in rats.
Horiuchi H, Ogata T, Morino T, Yamamoto
H
Spinal Cord. 2010, in press
40) Pharmacological shift of the ambiguous nitric oxide
(NO) action from neurotoxicity to cyclic GMP-mediated protection
Kohgami
S, Ogata T, Morino T, Yamamoto H, Schubert P
Neurological Res. 2010, in press
41) 3-D MRI/CT fusion
imaging of the lumbar spine.
Yamanaka Y, Kamogawa J,
Katagi R, Kodama K, Misaki H, Kamada K, Okuda S, Morino T, Ogata T, Yamamoto H.
Skeletal Radiol. 2010; 39: 285-288.